Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia

Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia

Background: Some risk classifications to determine prognosis of patients with non-muscle invasive bladder cancer (NMIBC) have disadvantages in the clinical setting. We investigated whether the EORTC (European Organization for Research and Treatment of Cancer) risk stratification is useful to predict...

Full description

Bibliographic Details
Main Authors: Takeshi Ieda, M.D., Ph.D., Satoru Muto, M.D., Ph.D., Fumitaka Shimizu, M.D., Ph.D., Masataka Taguri, M.D., Ph.D., Shigeto Yanada, M.D., Kousuke Kitamura, M.D., Ph.D., Kazutaka Terai, M.D., Ph.D., Keisuke Saito, M.D., Ph.D., Tatsuya Ogishima, M.D., Ph.D., Masayoshi Nagata, M.D., Ph.D., Hisamitsu Ide, M.D., Ph.D., Takatsugu Okegawa, M.D., Ph.D., Yoshiaki Wakumoto, M.D., Ph.D., Yoshiro Sakamoto, M.D., Ph.D., Akira Tsujimura, M.D., Ph.D., Raizo Yamaguchi, M.D., Ph.D., Kikuo Nutahara, M.D., Shigeo Horie, M.D.
Format: Article
Language:English
Published: Elsevier 2016-10-01
Series:EBioMedicine
Subjects:
Non-muscle invasive bladder cancer
Recurrence
Risk factor
Classification
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396416304054

Internet

http://www.sciencedirect.com/science/article/pii/S2352396416304054

Similar Items